Filing Details
- Accession Number:
- 0001209191-18-063832
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-21 14:03:29
- Reporting Period:
- 2018-12-20
- Accepted Time:
- 2018-12-21 14:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339469 | Chiasma Inc | CHMA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1520265 | J. Mark Fitzpatrick | C/O Chiasma, Inc. 460 Totten Pond Road, Suite 530 Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-20 | 9,612 | $2.50 | 9,612 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase was effected pursuant to a Rule 10b5-1 trading plan dated August 30, 2018 adopted by the Reporting Person.
Billionaire Hedge Funds
